Audubon Bioscience

We are happy to announce that Audubon Bioscience will attend the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Meeting, scheduled for July 28 - August 1, 2024.

(formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) allows us to connect with our existing research partners and meet new leaders in the global laboratory medicine community.

Planning to attend? We would be delighted to have a quick coffee chat to discuss how biospecimen procurement supports the latest advancements in diagnostics.

Arrange a meeting by emailing [email protected], or contact our conference team here - https://lnkd.in/dFtD8bBS

See you in Chicago!

Audubon Bioscience Co. will attend the 115th Annual Meeting of the American Association for Cancer Research (AACR), which will take place on April 5-10, 2024, in San Diego, California.

This year’s theme is “Inspiring Science, Fueling Progress, Revolutionizing Care”. It showcases today’s opportunities in oncology research, where enormous new discoveries are precipitating a revolution in how cancer is prevented, diagnosed, treated, and cured.

Our team will be available to meet to review an ongoing collaboration or to discuss new ones. If your research needs biospecimens and data, we’d love to be your partner.

Arrange a meeting by emailing [email protected] or contact our conference team here - https://bit.ly/4aqOBB1

🔬 As molecular diagnostics and drug discovery progresses forward, the role of biobanks will only increase, making them an essential component in biomedical research.

📑 In this article, we explained the role of biobanking in preclinical research, explored the hurdles researchers are currently facing, and potential solutions on the horizon that could mitigate these challenges.

➡ Read the full article here - https://bit.ly/4bDfSSh

The Need for Biobanking in Molecular Diagnostics & Drug Discovery This article explores the role of biobanking in molecular diagnostics and drug discovery, highlighting its contributions, challenges, and technological advancements.

DNA and RNA from FFPE matched sets allow clinicians to answer important questions such as:

📌Why did this treatment work for this patient and not another?
📌Why did the patient develop resistance after two months?
📌What mutations or transcriptome changes were associated with that resistance?

FFPE slides for IHC allow clinicians to monitor immune cell infiltration which is important for treatment efficacy in cancer.

Accelerate your drug discovery and diagnostic development with our FFPE matched sets.
Speak to our scientific team today - https://bit.ly/3SfNCh4

✅ Developing a greater understanding of biospecimen procurement is crucial for scientists and healthcare stakeholders, given its impact on personalized medicine advancement and therapeutic development.

Each step, from planning and collection to reporting and publication, must be conducted with precision to ensure quality results, good research conduct, and optimal biosample use. By successfully navigating this intricate process, researchers influence the reliability of patient outcomes, and in turn, the progress of scientific research.

Learn more from our latest blog article - https://bit.ly/3S8H6bo

A Comprehensive Guide to Modern Biospecimen Procurement Navigate the complex process of biospecimen procurement efficiently with our step-by-step guide. From planning to publication, improve the quality of your research outcomes and advance personalized medicine.